Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
- Department of Internal Medicine and Cardiology (at Dresden Heart Centre)
- Copenhagen University Hospitals
- Righospitalet
- Odense University Hospital
- Aarhus University Hospital (AUH)
- University Hospital Duesseldorf
- Charité – Universitätsmedizin Berlin
- University Hospital of Würzburg
- Royal Brompton and Harefield NHS Foundation Trust
- University of Bonn Medical Center
- Hannover Medical School (MHH)
- Hospital of the Brothers of Mercy Trier
- Jena University Hospital
- University Hospital Hamburg Eppendorf
Abstract
BACKGROUND: The optimal percutaneous coronary intervention (PCI) strategy in ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock and multivessel disease remains uncertain.
OBJECTIVES: The aim of this study was to investigate the association between PCI strategy and outcomes in STEMI-related cardiogenic shock and multivessel disease.
METHODS: This exploratory substudy of the DanGer Shock (Danish-German Cardiogenic Shock) multicenter trial included patients with STEMI-related cardiogenic shock and multivessel disease, excluding comatose patients resuscitated from cardiac arrest. Multivessel disease was defined by ≥1 nonculprit angiographic stenosis ≥70%. Patients with an isolated left main culprit were excluded. The planned PCI strategy was registered before randomization. All analyses were performed according to as-treated PCI strategy (immediate multivessel PCI or culprit-only PCI). The primary outcome was all-cause mortality within 180 days; secondary outcomes included renal replacement therapy and acute kidney injury.
RESULTS: Of 355 patients included in the DanGer Shock trial, 221 (72%) had multivessel disease; of these, 118 (53%) were treated with culprit-only PCI and 103 (47%) with immediate multivessel PCI. The median pre-PCI SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) scores were 28 (Q1-Q3: 22-32) and 29 (Q1-Q3: 22-34), respectively. Chronic total occlusion PCI was performed in 6 of 103 patients (6%) treated with immediate multivessel PCI. All-cause mortality was 72 (61%; 95% CI: 52%-70%) in the culprit-only group and 52 (50%; 95% CI: 41%-60%) in the immediate multivessel PCI group (adjusted OR: 0.40; 95% CI: 0.19-0.83) over a median follow-up period of 45 days (Q1-Q3: 2-180 days). Immediate multivessel PCI was not associated with the secondary outcomes. There was no interaction according to randomization allocation and PCI strategy (P = 1.00).
CONCLUSIONS: Immediate multivessel PCI was associated with 60% lower odds of all-cause mortality compared with culprit-only PCI.
Details
| Original language | English |
|---|---|
| Pages (from-to) | 2226-2237 |
| Number of pages | 12 |
| Journal | JACC. Cardiovascular interventions |
| Volume | 18 |
| Issue number | 18 |
| Publication status | Published - 22 Sept 2025 |
| Peer-reviewed | Yes |
External IDs
| Scopus | 105015888801 |
|---|
Keywords
ASJC Scopus subject areas
Keywords
- STEMI, cardiogenic shock, multivessel PCI, multivessel disease